Invesco Nasdaq Biotechnology ETF (IBBQ)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary 
XBER $
32. 62
+0.03
+0.0921%
$
46.82M Market Cap
0.2% Div Yield
14,200 Volume
$ 32.59
Previous Close 
Want to track IBBQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
5 Undervalued ETFs to Ride on Powell's Market Optimism
The Fed lifted market confidence amid economic uncertainty, leading to a rally in the U.S. stock market.
Zacks | 1 year ago
IBBQ: This Low-Cost Biotech ETF Comes With Unique Risks
IBBQ is a relatively new U.S. biotech ETF that competes with established peers like IBB and XBI. IBBQ has outperformed both since its June 2021 launch date. However, there are specific risks investors should consider first. In addition to the volatile nature of the biotech industry, I'll review IBBQ's liquidity, concentration, and quality features in detail. IBBQ also has a high liquidation risk. With only $38 million in assets under management and a 0.19% expense ratio, IBBQ likely isn't a profitable product for Invesco.
Seekingalpha | 1 year ago
